• Ingrid Glurich Ph.D.

  • Emeritus Researcher


    • MCRI - MCRI-Integr Resrch and Dev Lab
    • 1000 North Oak Ave. 1R4 Marshfield, WI 54449
    • (715) 389-3072

Education

1987:
PhD, Microbiology, State University of New York at Buffalo, Buffalo
1985:
MS, Microbiology, State University of New York at Buffalo, Buffalo
1976:
BS, Medical Technology, State University of New York at Buffalo, Buffalo

Work Experience

2015 to Present:
Project Scientist, Institute for Oral and Systemic Health, Biomedical Informatics Research Center, Marshfield Clinic Research Foundation, Marshfield
2007 to Present:
University Associate, University of Stevens Point, Stevens Point
2000 to 2015:
Director, Office of Scientific Writing and Publication, Department of Medical Research, Marshfield Clinic Research Foundation, Marshfield
1995 to 1999:
Assistant Professor, Department of Oral Biology, School of Dentistry SUNY at Buffalo, Buffalo

Statement

Dr. Glurich is a microbiologist with expertise and training in oral immunity, autoimmune diseases, microbial pathogenesis. Her research interests span relationships between oral and systemic health, advancement of integrated care delivery, promotion of oral precision medicine and definition of clinical practice guidelines for oral health management in patients with rare disease impacted by oral, craniofacial abnormalities. She works as a project scientist advancing research intiatives within the Center for Oral and Systemic Health and serves as the Core leader for the Oral Precision Research Core.

Research Interests

Dr. Glurich's areas of interest include: oral microbiology including the role of oral microbiome in oral and systemic health, microbial pathogenesis, host immune responses, role of inflammation in disease establishment/progression, potential of identifying biomarkers for monitoring of oral disease status to promote clinical precision medicine, and further delineation of mechanisms underlying connections between oral and systemic disease processes. She also is interested in advancing integrated medical-dental care delivery and advancing understanding of oral and craniofacial abnormalities arising in the context of rare diseases that impact on oral and systemic health and establishment of clinical practice guidelines to assist dental and medical providers in interventional planning and management of affected individuals.

Select Publications

  • Penner E, Albini B, Glurich IE, Andres GA, Milgrom F. (1982). Dissociation of immune complexes in tissue sections by excess of antigen. Int Arch Allergy Appl Immunol.. 67(3):245-53.
  • Penner E, Albini B, Glurich I, Andres GA, Milgrom F. Dissociation of immune complexes in tissue sections by excess of antigen. Int Arch Allergy Appl Immunol. 1982 January; 67(3):245-53.
    PubMed ID: 6460702
  • Albini B, Nisengard RJ, Glurich IE, Neiders ME, Stinson M. (1985 March). Streptococcus mutans-induced nephritis in rabbits. Am J Pathol. 118(3):408-18.
  • Albini B, Nisengard RJ, Glurich I, Neiders ME, Stinson MW. Streptococcus mutans-induced nephritis in rabbits. Am J Pathol. 1985 March; 118(3):408-18. PMCID: PMC1887933.
    PubMed ID: 3976844
  • Kulesz-Martin M, Kozlowski P, Glurich IE, Lisafeld B, Hemedinger E, Kumar VR. (1989 July). Pemphigoid, pemphigus and desmoplakin as antigenic markers of differentiation in normal and tumorigenic mouse keratinocyte lines. Cell Tissue Kinet.. 22(4):279-90.
  • Kulesz-Martin M, Kozlowski P, Glurich I, Lisafeld B, Hemedinger E, Kumar V. Pemphigoid, pemphigus and desmoplakin as antigenic markers of differentiation in normal and tumorigenic mouse keratinocyte lines. Cell Tissue Kinet. 1989 July; 22(4):279-90.
    PubMed ID: 2691098
  • Kulesz-Martin M, Glurich IE, Lisafeld B, Kozlowski P. (1990 February). Induction by transforming growth factor beta of pemphigus vulgaris antigen activity in mouse papilloma cells. Cancer Res. 50(3):686-90.
  • Kulesz-Martin M, Glurich I, Lisafeld B, Kozlowski P. Induction by transforming growth factor beta of pemphigus vulgaris antigen activity in mouse papilloma cells. Cancer Res. 1990 February 1; 50(3):686-90.
    PubMed ID: 2404575
  • Glurich IE, Winters B, Albini B, Stinson M. (1991 March). Identification of Streptococcus pyogenes proteins that bind to rabbit kidney in vitro and in vivo. Microb Pathog. 10(3):209-20.
  • Glurich I, Winters B, Albini B, Stinson M. Identification of Streptococcus pyogenes proteins that bind to rabbit kidney in vitro and in vivo. Microb Pathog. 1991 March; 10(3):209-20.
    PubMed ID: 1895923
  • Miyata M, Glurich IE, Kasukawa R, Milgrom F, Stinson M, Albini B. (1995 December). Streptococcus-mutans-induced nephritis in rabbits: rheumatoid factors and nephritogenicity. Int Arch Allergy Immunol.. 108(4):360-7.
  • Miyata M, Glurich I, Kasukawa R, Milgrom F, Stinson M, Albini B. Streptococcus-mutans-induced nephritis in rabbits: rheumatoid factors and nephritogenicity. Int Arch Allergy Immunol. 1995 December; 108(4):360-7.
    PubMed ID: 7580309
  • Sharma AD, Sojar HT, Glurich IE, Honma K, Kuramitsu HK, Genco RJ. (1998 December). Cloning, expression, and sequencing of a cell surface antigen containing a leucine-rich repeat motif from Bacteroides forsythus ATCC 43037. Infect Immun. 66(12):5703-10.
  • Sharma A, Sojar HT, Glurich I, Honma K, Kuramitsu HK, Genco RJ. Cloning, expression, and sequencing of a cell surface antigen containing a leucine-rich repeat motif from Bacteroides forsythus ATCC 43037. Infect Immun. 1998 December; 66(12):5703-10. PMCID: PMC108721.
    PubMed ID: 9826345
  • Genco RJ, Glurich IE, Haraszthy V, Zambon J, De Nardin E. Overview of risk factors for periodontal disease and implications for diabetes and cardiovascular disease. Compend Contin Educ Dent. 2001 February; 22(2 Spec No):21-3.
    PubMed ID: 19248254
  • Glurich IE, Grossi S, Albini B, Ho A, Shah R, Zeid R,...De Nardin E. Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Diagn Lab Immunol. 2002 March; 9(2):425-32.
    PubMed ID: 11874889
  • Caldwell MD, Berg RL, Glurich IE. Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype. Pharmacogenetics. 2004 August; 14(8):539-547.
    PubMed ID: 15284536
  • Glurich IE, Mazza JJ. Risk assessment model for venothromboembolism in post-hospitalized patients. Int Angiol. 2005 September; 24(3):250-254.
    PubMed ID: 16158034
  • Mazza JJ, Glurich IE, Chyou P, Linneman JG. Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res. 2005 November; 3(4):214-220.
    PubMed ID: 16303886
  • Bryce DA, Nelson J, Glurich IE, Berg RL. Intradiscal electrothermal annuloplasty therapy: a case series study leading to new considerations. WMJ. 2005 September; 104(6):39-46.
    PubMed ID: 16218315
  • Habash-Bseiso D, Glurich IE, Goldberg JW. Serologic testing in connective tissue diseases. Clin Med Res. 2005 July; 3(3):190-193.
    PubMed ID: 16160075
  • Raggio CL, Shukla SK, McPherson EW, Pauli RM, Rasmussen K, David DE,...Blank RD [including Glurich IE.] An analysis of PAX1 in the development of vertebral malformations. Clin Genet. 2005 November; 68(5):448-453.
    PubMed ID: 16207213
  • Glurich IE. Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. J Altern Complement Med. 2005 June; 11(3):433-439.
    PubMed ID: 15992226
  • Vidaillet HJ, Caldwell MD, Glurich IE, Berg RL, Schmelzer JR. A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data. Clin Med Res. 2005 August; 3(3):137-145.
    PubMed ID: 16160068
  • Koehn MA, Sandok EK, Glurich IE. Excessive daytime sleepiness and sleep complaints among children with epilepsy. Epilepsy Behav. 2006 February; 8(1):272-277.
    PubMed ID: 16352471
  • Raggio CL, Glurich IE, Rasmussen K, McPherson EW, Pauli RM, Shukla SK, Blank RD. DLL3 as a candidate gene for vertebral malformations. Am J Med Genet A. 2006 October; 140A(22):2447-2453.
    PubMed ID: 17041936
  • Glurich IE, McPherson EW, Ivacic LC, Rasmussen K, Raggio CL, Blank RD, Womack J. Evaluation of SLC35A3 as a candidate gene for human vertebral malformations. Am J Med Genet A. 2006 June; 140(12):1346-1348.
    PubMed ID: 16691598
  • Mazza JJ, Glurich IE. Recurrent venous thromboembolism in patients with and without anticoagulation after inferior vena caval filter placement. Int Angiol. 2006 March; 25(1):60-66.
    PubMed ID: 16520726
  • Caldwell MD, Berg RL, Zhang KQi, Glurich IE, Schmelzer JR, Vidaillet HJ. Evaluation of genetic factors for warfarin dose prediction. Clin Med Res. 2007 March; 5(1):8-16.
    PubMed ID: 17456829
  • Raggio CL, Blank RD, McPherson EW, Ivacic LC, Rasmussen K, Glurich IE,...Boachie-Adjei O. Lack of evidence of WNT3A as a candidate gene for congenital vertebral malformations. Scoliosis. 2007 September; 2 :13.
    PubMed ID: 17888180
  • Giampietro PF, Dunwoodie S, Kusumi K, Pourquie O, Tassy O, Offiah A,...Turnpenny PD. (2008 December). Molecular diagnosis of vertebral segmentation disorders in humans. Expert Opin Med Diagn. 2(10):1107-21.
  • Wesbrook SD, Giampietro PF, Glurich IE, McCarty CA, Peissig PL, Starren JB,...Vidaillet HJ [including Uphoff TS, Zaleski CA.] (2008 November). Marshfield Clinic, Marshfield Wisconsin/ Community Based Approaches to Personalized Health Care: Marshfield Clinic Personalized Health Care: Pioneers, Partnerships, Progress. :231-42.
  • Yale SH, Kieke AL, Glurich IE, Chyou P. Applying case definition criteria to irritable bowel syndrome. Clinical Medicine & Research. 2008 May; 6(1):9-16.
    PubMed ID: 18591372
  • Caldwell MD, Awad T, Johnson JA, Gage BF, Falkowski M, Gardina P,...Berg RL [including Schmelzer JR, Glurich IE, Vidaillet HJ, Zhang KQi.] CYP4F2 genetic variant alters required warfarin dose. BLOOD. 2008 April; 111(8):4106-12.
    PubMed ID: 18250228
  • Ghebranious N, Blank RD, Raggio CL, Staubli JC, McPherson EW, Ivacic LC,...Glurich IE [including Rasmussen K.] A missense T(Brachyury) Mutation Contributes to Vertebral Malformations. JOURNAL OF BONE AND MINERAL RESEARCH. 2008 October; 23(10):1576-83.
    PubMed ID: 18466071
  • Giampietro PF, Dunwoodie SL, Kusumi K, Pourquié O, Tassy O, Offiah AC,...Turnpenny PD [including Glurich I.] Molecular diagnosis of vertebral segmentation disorders in humans. Expert Opin Med Diagn. 2008 October; 2(10):1107-21.
    PubMed ID: 23496422
  • Bailey H, Agger WA, Baumgardner D, Cisler R, Everten J, Glurich IE,...DeMets D. The Wisconsin Network for Health Research (WiNHR): A Statewide, Collaborative, Multi-disciplinary, Research Group. Wis Med J. 2009 December; 108(9):453-458.
    PubMed ID: 20131687
  • Giampietro PF, Dunwoodie S, Kusumi K, Pourquie O, Tassy O, Offiah A,...Turnpenny PD [including Glurich IE.] Progress in the understanding of the genetic etiology of vertebral segmentation disorders in humans. Ann N Y Acad Sci. 2009 January; 1151 :38-67.
    PubMed ID: 19154516
  • Onitilo AA, Wilke RA, Glurich IE, Engel JM, Flockhart DA, Nguyen A,...Gin Y. Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. BREAST CANCER RESEARCH AND TREATMENT. 2009 June; 115(3):643-50.
    PubMed ID: 19082882
  • Glurich IE, Fleisner MA. Research Mentor: a web-based resource supporting grantsmanship and scientific publication. Clinical Medicine & Research. 2010 December; 8(3-4):173-75.
    PubMed ID: 20852087
  • Kumar DR, Hanlin E, Glurich IE, Mazza JJ. Virchow’s Contribution to the Understanding of Thrombosis and Cellular Biology. Clinical Medicine & Research. 2010 December; 8(3-4):168-72.
    PubMed ID: 20739582
  • Wiley CL, Switzer SP, Berg RL, Glurich IE, Dart RA. Association of B-type natriuretic peptide (BNP) levels with estimated glomerular filtration rate (eGFR) and congestive heart failure (CHF). Clinical Medicine & Research. 2010 March; 8(1):7-11.
    PubMed ID: 19920165
  • Glurich IE, Fleisner MA. (2010 March). Research Mentor: a web-based reference for planning and preparing a research proposal. Clinical Medicine & Research. 8(1):56.
  • Glurich IE, Caldwell MD. Understanding the pharmacogenetic approach to warfarin dosing. HEART FAILURE REVIEWS. 2010 May; 13(3):239-48.
    PubMed ID: 18998206
  • Yazigi N, Yale S, Glurich, I, Schmelzer, J, Burmester, J, Berg, R, Caldwell, M. (2010). Modeling Clearance of Warfarin - Preliminary Report. J Gen Intern Med. 25(Suppl 3):334.
  • Ghebranious N, Mukesh BNanjan, Giampietro PF, Glurich IE, Mickel SF. A pilot study of gene/gene and gene/environment interactions in Alzheimer disease. Clin Med Res. 2011 March; 9(1):17-25.
    PubMed ID: 20682755
  • Burmester JK, Berg RL, Yale SH, Rottscheit CM, Glurich IE, Schmelzer JR, Caldwell MD. A randomized controlled trial of genotype-based Coumadin initiation. Genet Med. 2011 June; 13(6):509-18.
    PubMed ID: 21423021
  • Berg RL, Glurich IE, Schmelzer JR, Caldwell MD. Absence of novel CYP4F2 and VKORC1 coding region DNA variants in patients requiring high warfarin doses. Clinical Medicine & Research. 2011 November; 9(3-4):119-24.
    PubMed ID: 21562135
  • Klimant E, Glurich IE, Mukesh BNanjan, Onitilo AA. Blood type, hormone receptor status, her2/neu status, and survival in breast cancer: a retrospective study exploring relationships in a phenotypically well-defined cohort. Clinical Medicine & Research. 2011 November; 9(3-4):111-8.
    PubMed ID: 21263059
  • Karnik SS, Tan SL, Berg B, Glurich IE, Zhang J, Vidaillet HJ, Page D. Predicting Atrial Fibrillation and Flutter using Electronic Health Records. Engineering in Medicine and Biology. 2012 April; 2012 :5562-5.
    PubMed ID: 23367189
  • Myklejord DJ, Yao L, Glurich IE. Consensus guideline adoption for managing postoperative nausea and vomiting. WMJ. 2012 October; 111(5):207-13; quiz 214.
    PubMed ID: 23189453
  • Tan SL, Pavesi G, Jin J, Dong D, Mathur SK, Burkart A,...Bajic VB [including Glurich IE.] A database of annotated promoters of genes associated with common respiratory and related diseases. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. 2012 July; 47(1):112-9.
    PubMed ID: 22383585
  • Onitilo AA, Engel JM, Glurich IE, Stankowski RV, Williams G, Doi SA. R.. Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. CANCER CAUSES & CONTROL. 2012 July; 23(7):991-1008.
    PubMed ID: 22527174
  • Onitilo AA, Engel JM, Glurich IE, Stankowski RV, Williams GH, Doi SA. R.. Diabetes and cancer I: risk, survival, and implications for screening. CANCER CAUSES & CONTROL. 2012 June; 23(6):967-81.
    PubMed ID: 22552844
  • Onitilo AA, Doi SA. R., Engel JM, Glurich IE, Johnson JC, Berg RL. Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: A population-based experience. THROMBOSIS RESEARCH. 2012 July; 130(1):27-31.
    PubMed ID: 22154240
  • Onitilo AA, Engel JM, Glurich IE. Long-Term Cardiac and Vascular Disease Outcomes Following Adjuvant Tamoxifen Therapy: Current Understanding of Impact on Physiology and Overall Survival, Minerva Medica. 2013 April; 104(2):141-53.
    PubMed ID: 23514990
  • Onitilo AA, Berg RL, Engel JM, Stankowski RV, Glurich IE, Williams GA, Doi SA. R.. Prostate Cancer Risk in Pre-Diabetic Men: A Matched Cohort Study. Clinical Medicine & Research. 2013 December; 11(4):201-9.
    PubMed ID: 23656798
  • Glurich IE, Chyou P, Engel JM, Onitilo AA. Tamoxifen-induced venothromboembolic events: exploring validation of putative genetic association. Clinical Medicine & Research. 2013 February; 11(1):16-25.
    PubMed ID: 23411630
  • Glurich IE, Berg RL. Does CALU SNP rs1043550 Contribute Variability to Therapeutic Warfarin Dosing Requirements? Clinical Medicine & Research. 2013 June; 11(2):73-9.
    PubMed ID: 23656803
  • Glurich IE, Acharya A, Shukla SK, Nycz G, Brilliant MH. The oral-systemic personalized medicine model at Marshfield Clinic. ORAL DISEASES. 2013 January; 19(1):1-17. doi: 10.1111/j.1601-0825.2012.01921.x. PMCID: PMC3389173.
    PubMed ID: 22458294
  • Onitilo AA, Doi SA. R., Engel JM, Glurich IE, Berg RL. Relationship between Factor V Leiden mutation and venous thromboembolism in patients with breast cancer treated with tamoxifen. THROMBOSIS RESEARCH. 2013 June; 131(6):567-8.
    PubMed ID: 23497923
  • Onitilo AA, Berg RL, Engel JM, Glurich IE, Stankowski RV, Williams G, Doi SA. R.. Increased risk of colon cancer in men in the pre-diabetes phase. PLoS One. 2013 August; 8(8):E70426.
    PubMed ID: 23936428
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich IE, Williams G, Doi SA. R.. Type 2 diabetes mellitus, glycemic control, and cancer risk. EUROPEAN JOURNAL OF CANCER PREVENTION. 2014 March; 23(2):134-40.
    PubMed ID: 23962874
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich IE, Williams G, Doi SA. R.. Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase. EUROPEAN JOURNAL OF CANCER PREVENTION. 2014 March; 23(2):76-83.
    PubMed ID: 23571511
  • Glurich I, Acharya A, Brilliant MH, Shukla SK. Progress in oral personalized medicine: contribution of 'omics'. J Oral Microbiol. 2015 September 4; 7 :28223.
    PubMed ID: 26344171
  • Peissig PL, Nikolai A, Glurich I, Brilliant M. (2015 March 20). Drug Discover and Evaluation: Pharmacological Assays. Personalized Medicine. :1-16.
  • Shimpi N, Schroeder D, Kilsdonk J, Chyou PH, Glurich I, Acharya A. (2016 February 8). Assessment of Dental Providers’ Knowledge, Behavior and Attitude towards Incorporating Chairside Screening for Medical Conditions: A Pilot Study. Journal of Dentistry and Oral Care Medicine. 2(1):102.
  • Shimpi N, Schroeder D, Kilsdonk J, Chyou PH, Glurich I, Penniman E, Acharya A. Medical Providers' Oral Health Knowledgeability, Attitudes, and Practice Behaviors: An Opportunity for Interprofessional Collaboration. J Evid Based Dent Pract. 2016 March; 16(1):19-29.
    PubMed ID: 27132552
  • Shimpi N, Bharatkumar A, Jethwani M, Chyou PH, Glurich I, Blamer J, Acharya A. Knowledgeability, Attitude and Behavior of Primary Care Providers Towards Oral Cancer: a Pilot Study. [published online ahead of print 2016 July 23]. J Cancer Educ. 2018 Apr(33(2)):359-364. doi: 10.1007/s13187-016-1084-4.
    PubMed ID: 27448614
  • Panny A, Glurich I, Haws RM, Acharya A. Oral and Craniofacial Anomalies of Bardet-Biedl Syndrome: Dental Management in the Context of a Rare Disease. [published online ahead of print 2017 June 1]. J Dent Res. :22034517716913.
    PubMed ID: 28662344
  • Glurich I, Nycz G, Acharya A. Status Update on Translation of Integrated Primary Dental-Medical Care Delivery for Management of Diabetic Patients. Clin Med Res. 2017 June; 15(1-2):21-32.
    PubMed ID: 28373288
  • Glurich I, Schwei KM, Lindberg S, Shimpi N, Acharya A. Integrating Medical-Dental Care for Diabetic Patients: Qualitative Assessment of Provider Perspectives. [published online ahead of print 2017 October 1]. Health Promot Pract. :1524839917737752.
    PubMed ID: 29073800
  • Shimpi N, Ye Z, Koralkar R, Glurich I, Acharya A. Need for diagnostic-centric care in dentistry: A case study from the Marshfield Clinic Health System. J Am Dent Assoc. 2018 February; 149(2):122-131. doi: 10.1016/j.adaj.2017.09.030. PMCID: PMC5798006.
    PubMed ID: 29389335
  • Shimpi N, Jethwani M, Bharatkumar A, Chyou PH, Glurich I, Acharya A. Patient awareness/knowledge towards oral cancer: a cross-sectional survey. BMC Oral Health. 18(1):86. doi: 10.1186/s12903-018-0539-x. PMCID: PMC5952627.
    PubMed ID: 29764414
  • Hegde H, Shimpi N, Glurich I, Acharya A. Tobacco use status from clinical notes using Natural Language Processing and rule based algorithm. Technol Health Care. 2018 June 29; 26(3):445-456. doi: 10.3233/THC-171127.
    PubMed ID: 29614708
  • Shimpi N, Glurich I, Schroeder D, Katrak C, Chyou PH, Acharya A. Patient Awareness of Association of Diabetes and Periodontal Disease. [published online ahead of print 2018 September 21]. Health Promot Pract. 20201, May(21(3)):464-472. doi: 10.1177/1524839918801909. PMCID: PMC5952627.
    PubMed ID: 30238811
  • Glurich I, Bartkowiak B, Berg RL, Acharya A. Screening for dysglycaemia in dental primary care practice settings: systematic review of the evidence. Int Dent J. 2018 December; 68(6):369-377. PMCID: PMC9379002.
    PubMed ID: 29740815
  • Delli K, Villa A, Farah CS, Celentano A, Ojeda D, Peterson D,...Vissink A [including Glurich I.] World Workshop on Oral Medicine VII: Biomarkers predicting lymphoma in the salivary glands of patients with Sjögren's syndrome. A systematic review. [published online ahead of print 2019 January 21]. Oral Dis. doi: 10.1111/odi.13041.
    PubMed ID: 30663837
  • Shimpi N, Glurich I, Panny A, Acharya A. Knowledgeability, Attitude and Practice Behaviors of Primary Care Providers Towards Managing Patient's Oral Health in Medical Practice: Wisconsin Statewide Survey. [published online ahead of print 2019 August 22]. J Am Dent Assoc. 2019 Oct(150(10)):863-872. doi: 10.1016/j.adaj.2019.05.020. PMCID: PMC6765414.
    PubMed ID: 31446976
  • Glurich I, Zhang L, Berg R, Acharya A. Periodontitis and CKD: Parallel Examination of Prevalence and Longitudinal Exacerbation. J Dent Res. 2019 June; (98 (Spec Iss A): 3876):iadr.org.
  • Steinmetz A, Glurich I, Panny A, Berg R, Fischer G, Acharya A. HbA1C Screening in the Dental Setting. J Dent Res. 2019 June; (98 (Spec Iss A): 1782):iadr.org.
  • Shimpi N, Zhang L, Jhagroo R, Acharya A, Glurich I. Dental Pulp Stones Prevalence in Patients with Nephrolithiasis and Co-morbidities. J Dent Res. 2019 June; (98 (Spec Iss A): 1796):iadr.org.
  • Glurich I, Acharya A. Updates from the Evidence Base Examining Association between Periodontal Disease and Type 2 Diabetes Mellitus: Current Status and Clinical Relevance. Curr. Diab. Rep.. 2019 November 6; 19(11):121.
    PubMed ID: 31696343
  • Hegde, H, Shimpi, N, Panny, A, Glurich, I, Christie, P, Acharya, A. Development of Non-Invasive Diabetes Risk Prediction Models as Decision Support Tools Designed for Application in the Dental Clinical Environment. Informatics in Medicine-Unlocked. 2019 December; 2019(17):100254. doi: 10.1016/j.imu.2019.100254. PMCID: PMC7453822.
    PubMed ID: 32864420
  • Hegde, H, Shimpi, N, Panny, A, Glurich, I, Christine, P, Acharya, A. MICE vs PPCA: Missing data imputation in healthcare. [published online ahead of print 2019 December]. 17(100275)
  • Villa A, Celentano A, Glurich I, Borgnakke WS, Jensen SB, Peterson DE,...Farah CS. Response to "prognostic biomarkers in oral leukoplakia". Oral Dis. 2019 November; 25(8):2048-2049.
    PubMed ID: 31469945
  • Villa A, Celentano A, Glurich I, Borgnakke WS, Jensen SB, Peterson DE,...Farah CS. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia: A systematic review of longitudinal studies. Oral Dis. 2019 June; 25 Suppl 1(Suppl 1):64-78. PMCID: PMC6544170.
    PubMed ID: 31140698
  • Acharya A, Glurich I, Hetzel S, Kim K, Tattersall MC, DeMets DL, Hennekens CH. Correlation between Oral Health and Systemic Inflammation (COHESION): A Randomized Pilot Follow Up Trial of a Plaque Identifying Toothpaste. [published online ahead of print 2020 February 17]. Am J Med.
    PubMed ID: 32105658
  • Al Dhaheri N, Wu N, Zhao S, Wu Z, Blank RD, Zhang J,...Giampietro PF [including Glurich I, Steiner RD.] KIAA1217: A novel candidate gene associated with isolated and syndromic vertebral malformations. [published online ahead of print 2020 May 5]. Am J Med Genet A.
    PubMed ID: 32369272
  • Nycz G, Shimpi N, Glurich I, Ryan M, Sova G, Weiner S,...Acharya A. Positioning operations in the dental safety net to enhance value-based care delivery in an integrated health-care setting. J Public Health Dent. 2020 September; 2020, Sep(80 Suppl 2):S71-S76. doi: 10.1111/jphd.12392.
    PubMed ID: 32885424
  • Gregory Nycz, Neel Shimpi, Ingrid Glurich, Megan Ryan, Gwen Sova, Sarah Weiner,...Amit Acharya. Positioning operations in the dental safety net to enhance value-based care delivery in an integrated health-care setting. Journal of Public Health Dentistry. 2020 September; 80(52):S71-S76. doi: https://doi.org/10.1111/jphd.12392 .
  • R. Lamont (Monty) MacNeil, Helena Hilario, Megan M. Ryan, Ingrid Glurich, Greg R. Nycz, Amit Acharya. The case for integrated oral and primary medical health care delivery: Marshfield Clinic Health System. Journal of Dental Education. 2020 August; 84 doi: https://onlinelibrary.wiley.com/doi/epdf/10.1002/jdd.12289 .
  • Gregory Nycz, Amit Acharya, Ingrid Glurich. Solutions to dental access disparity: Blueprint of an innovative community health center-based model for rurally based communities. Journal of Public Health Dentistry. 2020 January; 80 doi: https://doi.org/10.1111/jphd.12347.
  • Nycz G, Acharya A, Glurich I. Solutions to dental access disparity: Blueprint of an innovative community health center-based model for rurally based communities. J Public Health Dent. 2020 January; 80(1):4-8.
    PubMed ID: 31664717
  • MacNeil RLM, Hilario H, Ryan MM, Glurich I, Nycz GR, Acharya A. The case for integrated oral and primary medical health care delivery: Marshfield Clinic Health System. J Dent Educ. 2020 August; 84(8):924-931.
    PubMed ID: 32638376
  • Shimpi N, Panny A, Glurich I, Chyou P, Acharya A. Knowledgeability, Attitude and Practice Behaviors of Dental Providers Toward Provisions of Integrated Care Delivery for Patients With Prediabetes/Diabetes: Wisconsin Statewide Survey. [published online ahead of print 2021 November 2]. Frontiers in Dental Medicine. 2 doi: https://doi.org/10.3389/fdmed.2021.674178.
  • Neel Shimpi, Harshad Hegde, Ingrid Glurich, Megan Ryan, Amit Acharya. ESTABLISHING A QUALITY IMPROVEMENT CULTURE WITHIN A LARGE INTEGRATED MEDICAL-DENTAL HEALTH SYSTEM WITH A POPULATION BASED FOCUS. Journal of Evidence Based Dental Practice. 2021 December 1; 21(4):101589. doi: https://doi.org/10.1016/j.jebdp.2021.101589 .
  • Neel Shimpi, Ingrid Glurich, Catherine Maybury, Min Qi Wang, Kazumasa Hashimoto, Amit Acharya, Alice M. Horowitz. Knowledge, Attitudes, Behaviors of Women Related to Pregnancy, and Early Childhood Caries Prevention: A Cross-Sectional Pilot Study. Journal of Primary Care & Community Health. 2021 January; 12 doi: https://doi.org/10.1177/21501327211013302. PMCID: PMC8114310.
    PubMed ID: 33949227
  • Ingrid Glurich, Richard Berg, Aloksagar Panny, Neel Shimpi, Annie Steinmetz, Greg Nycz, Amit Acharya. Longitudinal Observation of Outcomes and Patient Access to Integrated Care Following Point-of-Care Glycemic Screening in Community Health Center Dental Safety Net Clinics. [published online ahead of print 2021 May 26]. Frontiers in Oral Health. 2 doi: https://doi.org/10.3389/froh.2021.670355 .
  • Antonio Celentano, Ingrid Glurich, Wenche S. Borgnakke, Camile S. Farah. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia and proliferative verrucous leukoplakia—A systematic review of retrospective studies. Oral Diseases. 2021 May; 27 doi: https://onlinelibrary.wiley.com/doi/epdf/10.1111/odi.13363 .
  • Glurich I, Berg R, Panny A, Shimpi N, Steinmetz A, Nycz G, Acharya A. Longitudinal Observation of Outcomes and Patient Access to Integrated Care Following Point-of-Care Glycemic Screening in Community Health Center Dental Safety Net Clinics. Front Oral Health. 2021 May 26; 2 :670355. doi: 10.3389/froh.2021.670355. PMCID: PMC8757706.
    PubMed ID: 35048014
  • Shimpi N, Hegde H, Glurich I, Ryan M, Acharya A. ESTABLISHING A QUALITY IMPROVEMENT CULTURE WITHIN A LARGE INTEGRATED MEDICAL-DENTAL HEALTH SYSTEM WITH A POPULATION BASED FOCUS. J Evid Based Dent Pract. 2021 December 21; 21(4):101589. doi: 10.1016/j.jebdp.2021.101589.
    PubMed ID: 34922728
  • Shao K, Pu W, Zhang J, Guo S, Qian F, Glurich I,...Ding W. DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter. Clin Epigenetics. 2021 April 23; 13(1):89. PMCID: PMC8063327.
    PubMed ID: 33892791
  • Celentano A, Glurich I, Borgnakke WS, Farah CS. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia and proliferative verrucous leukoplakia-A systematic review of retrospective studies. Oral Dis. 2021 April 23; 27(4):848-880. doi: 10.1186/s13148-021-01071-z. PMCID: PMC8063327.
    PubMed ID: 32306449
  • Hegde H, Glurich I, Panny A, Vedre JG, VanWormer JJ, Berg R,...Acharya A. Identifying Pneumonia Sub-types from Electronic Health Records Using Rule-based Algorithms. J. Matern. Fetal. Neonatal. Med.. 2022 December; 61(1-02):29-37. doi: 10.1055/a-1801-2718. PMCID: PMC9391271.
    PubMed ID: 35299265
  • Panny A, Hegde H, Glurich I, Scannapieco FA, Vedre JG, VanWormer JJ,...Acharya A. A methodological approach to validate pneumonia encounters from radiology reports using Natural Language Processing (NLP). [published online ahead of print 2022 April 5]. Methods Inf Med. 61(1-02):38-45. doi: 10.1055/a-1817-7008. PMCID: PMC9391313.
    PubMed ID: 35381617
  • Shimpi N, Glurich I, Rostami R, Hegde H, Olson B, Acharya A. Development and Validation of a Non-Invasive, Chairside Oral Cavity Cancer Risk Assessment Prototype Using Machine Learning Approach. J Pers Med. 2022 April 11; 12(4):614. doi: 10.3390/jpm12040614. PMCID: PMC9032985.
    PubMed ID: 35455730
  • Glurich I, Shimpi N, Bartkowiak B, Berg RL, Acharya A. Systematic review of studies examining contribution of oral health variables to risk prediction models for undiagnosed Type 2 diabetes and prediabetes. Clin Exp Dent Res. 2022 February; 8(1):96-107. doi: 10.1002/cre2.515. PMCID: PMC8874063.
    PubMed ID: 34850592
  • Shimpi N, Glurich I, Panny A, Hegde H, Scannapieco FA, Acharya A. Identifying oral disease variables associated with pneumonia emergence by application of machine learning to integrated medical and dental big data to inform eHealth approaches. Front Dent Med. 2022 September; 3 :1005140. doi: 10.3389/fdmed.2022.1005140. PMCID: PMC9835559.
    PubMed ID: 36643095
  • Shimpi N, Glurich I, Gabor R, Chyou PH, Nycz G, Acharya A. Impact of Establishing Dental Access for Preventable Infectious Dental Diseases (PIDD) in Medical Settings: Case Study from Rural Wisconsin. Community Dent Health. 2023 February 28; 40(1):23-29. doi: 10.1922/CDH_00102Shimpi07.
    PubMed ID: 36269067
  • Shimpi N, Glurich I, Hegde H, Steinmetz A, Kuester R, Crespin M, Acharya A. DentaSeal: A school-based dental sealant efficiency assessment tool to support statewide monitoring and reporting: A field report. [published online ahead of print 2023 January 5]. Technol Health Care. doi: 10.3233/THC-220568.
    PubMed ID: 36641695
  • Berg RL, Glurich I, Panny A, Scannapieco FA, Miecznikowski J, VanWormer J, Acharya A. Modeling longitudinal oral health status and pneumonia risk: secondary data analyses of an integrated dental-medical cohort. BMC Oral Health. 2023 December 1;23(1):950. doi: 10.1186/s12903-023-03629-0. PMCID: PMC10690969.
    PubMed ID: 38041050